NewsRoom Articles - Page 125 of 214

WednesdayJan 26, 2022 1:19 pm

Experts Forecast Increase in Brain Cancer in the US

Brain tumors are noncancerous or cancerous masses or growths of abnormal cells in the brain. Brain cancer usually originates in the central nervous system, which is made up of the spinal cord and the brain. Over the last 10 years, this serious and often debilitating ailment has been discussed and well documented, despite it not being as common as other types of cancer. Research has shown that brain cancer is more common in men, with epidemiologists from GlobalData predicting that over one-half of all newly diagnosed cases in the United States being individuals aged 60 and above. They expect this…

WednesdayJan 26, 2022 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market

The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029 InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoids It is shedding light on the potential of rare cannabinoids and laying the groundwork on how to tap into the industry’s growth It is projected that by 2025, the global cannabis market will be valued at around $146 billion, up from just $20.47 billion in 2020. This sector is experiencing tremendous growth, particularly considering that there are over one hundred known cannabinoids, including rare ones that are quickly…

TuesdayJan 25, 2022 11:38 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement

CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company, which dosed the first patients in its Berubicin program in September, has selected multiple clinical sites across the U.S., Spain, France, Italy, and Switzerland CNS recently closed an $11.5 million private placement It intends to use the net proceeds to fund its clinical trials and preclinical programs, other R&D programs, and for general corporate purposes Clinical stage biotechnology company CNS Pharmaceuticals (NASDAQ: CNSP) is celebrating…

TuesdayJan 25, 2022 10:37 am

Experts Discuss Addiction and How to Support Individuals Battling the Disease

Researchers at the University of Virginia are conducting new research that will assist in identifying and helping individuals who are struggling with addiction, through the institution’s Center for Leading Edge Addiction Research (“CLEAR”), which develops addiction treatments. Data from the National Center for Drug Abuse Statistics shows that between 2009 and 2019, the number of overdose-related fatalities recorded for individuals aged 15 to 24 grew to 4,777 from less than 3,400 deaths. This increase has been linked to opioid overdoses, some of which are caused by fentanyl laced cocaine. Studies by the Addiction Center have found that in comparison to…

MondayJan 24, 2022 1:21 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution

Nemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devices The company recently announced the rollout of its Miboko application by targeting insurers and employers In 2019, over $760 billion was spent on diabetes-related health care, equating to $9,000 per diabetic patient compared to $1,600 for a non-diabetic individual The Miboko application provides users with an efficient and accurate means of tracking their day-to-day glycaemic levels, a key determinant of overall metabolic health Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs,…

MondayJan 24, 2022 12:30 pm

Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Plans Program to Provide Resources for Safe, Effective Integration of Psychedelic-Assisted Psychotherapies into Existing Medical Practices

Mydecine plans to launch a program to provide products and services to healthcare professionals, clinics, and hospitals in Canada looking to treat patients through psychedelic-assisted psychotherapy The products and services, which will be available for purchase as a package, include cGMP psilocybin and MDMA, therapy manuals, investigative brochures, protocol training, advisory services, and post-therapy support The planned launch follows an amendment to federal regulations allowing physicians to request and prescribe restricted drugs for treatment-resistant patients Canada began the year on a high note by updating the Special Access Program (“SAP”), a move that demonstrates the government’s serious consideration of the…

MondayJan 24, 2022 9:30 am

Four Major Healthcare Tech Trends to Look for This Year

Many technology companies have used their expertise to solve issues caused by the coronavirus pandemic over the last two years, with healthcare companies also shifting their focus to technology and its potential to change how products and services are delivered. The global pandemic has sped up the digitization of the healthcare industry, with data from HIMSS Future of Healthcare Report showing that more than 75% of healthcare providers plan to increase their investment in digital solutions and technology over the next five years. This means that we will see growth in many areas, including wearables, genomics, personalized medicine and telemedicine,…

FridayJan 21, 2022 9:30 am

Exploring the Link Between OCD and Depression

Obsessive compulsive disorder (“OCD”) is characterized by excessive thoughts that cause compulsive behaviors while depression is a mental health disorder characterized by a loss of interest in daily activities and a constant depressed mood.Estimates from the International OCD Foundation show that roughly 25–50% of individuals with obsessive-compulsive disorder will also experience depression. Most individuals usually experience symptoms of obsessive compulsive disorder first. However, the conditions can begin at the same time for a small number. Can depression lead to OCD and vice versa? Data from the National Institute of Mental Health shows that compulsive disorder can be caused by childhood…

ThursdayJan 20, 2022 1:20 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee

Diabetes tech market expanded in 2021 due to new users, growing demand for CGM devices, coverage of CGM devices by CMS Diabetes is a growing problem in the US. According to CDC, roughly 1 in 10 Americans have diabetes, and 1 in 3 have pre-diabetes NMRD currently commercializing the sugarBEAT(R) non-invasive and flexible continuous glucose monitor Company recently completed initial shipment to UK licensee While most medical technology businesses faced COVID-19-related restrictions (https://ibn.fm/NJbOa), Nemaura Medical (NASDAQ: NMRD), a medical technology company that develops affordable diagnostic and digital tools for diabetes management, is favorably positioned in the rapidly growing diabetes tech…

ThursdayJan 20, 2022 9:30 am

Study Finds That New Lung Cancer Screening Guidelines Increase Eligibility for Black Women

A new study conducted by researchers from the University of California-Berkeley, the Northeastern University and Boston University has found that the new screening guidelines for lung cancer have significantly grown the eligibility of Black women. The U.S. Preventative Services Taskforce, which is made up of experts in evidence-based and preventative medicine, changed the lung cancer screening guidelines in April 2021 by reducing the required smoking “pack-years” to 20 from 30 and lowering the screening age of eligibility to 50, from 55. According to a research letter recently published in “JAMA Oncology,” these changes were made in order to increase the…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Experts Forecast Increase in Brain Cancer in the US

InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Marks Significant Milestone in Pursuit of Berubicin Approval for Global GBM Treatment, Raises $11.5 Million from Private Placement

Experts Discuss Addiction and How to Support Individuals Battling the Disease

Nemaura Medical Inc. (NASDAQ: NMRD) Commence Rollout of Their Miboko Application; Company Targets Employers & Insurers to Ensure Broad Commercial Distribution

Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Plans Program to Provide Resources for Safe, Effective Integration of Psychedelic-Assisted Psychotherapies into Existing Medical Practices

Four Major Healthcare Tech Trends to Look for This Year

Exploring the Link Between OCD and Depression

Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee

Study Finds That New Lung Cancer Screening Guidelines Increase Eligibility for Black Women

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search